Maximizing clinical benefit with trastuzumab

被引：25
|
作者：
Bell, R
Verma, S
Untch, M
Cameron, D
Smith, I
机构：
[1] Geelong Hosp, Andrew Love Canc Ctr, Geelong, Vic, Australia
[2] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada
[3] Univ Munich, Munich, Germany
[4] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[5] Royal Marsden Hosp, London SW3 6JJ, England
来源：
SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2004.07.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 44
页数：10
相关论文
共 50 条
  • [1] Maximizing the benefit of liver transplantation: Implications for organ allocation and clinical practice
    Volk, Michael L.
    TRANSPLANTATION REVIEWS, 2016, 30 (01) : 1 - 2
  • [2] Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis
    Elsayad, Khaled
    Oertel, Michael
    Koenig, Laila
    Hueske, Sebastian
    Le Ray, Emmanuelle
    Meheissen, Mohamed A. M.
    Elsaid, Amr Abdelaziz
    Elfaham, Essam
    Debus, Juergen
    Kirova, Youlia
    Herfarth, Klaus
    Eich, Hans Theodor
    CANCERS, 2020, 12 (03)
  • [3] Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity
    Kun-Wei Song
    Tracy Batchelor
    Current Oncology Reports, 2021, 23
  • [4] Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: An international multicenter analysis
    Oertel, M.
    Elsayad, K.
    Koenig, L.
    Hueske, S.
    Ray, L.
    Meheissen, M. A. M.
    Elsaid, A. A.
    Elfaham, E.
    Debus, J.
    Kirova, Y.
    Herfarth, K.
    Eich, H. -T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S23 - S23
  • [5] Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity
    Song, Kun-Wei
    Batchelor, Tracy
    CURRENT ONCOLOGY REPORTS, 2021, 23 (11)
  • [6] Reducing harm and maximizing benefit
    Clarkson, J
    Worthington, H
    Chalmers, I
    BRITISH DENTAL JOURNAL, 1999, 1 (02) : 4 - 5
  • [7] Estrogen receptor status in the Herceptin (trastuzumab) clinical trials: incidence and relation to clinical benefit.
    Mass, R
    Cobleigh, M
    Vogel, C
    Slamon, D
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 302 - 302
  • [8] Reducing harm and maximizing benefit
    Jan Clarkson
    Helen Worthington
    Iain Chalmers
    Evidence-Based Dentistry, 1999, 1 (2) : 4 - 5
  • [9] Maximizing the tax benefit of interest
    Glassman, GI
    VETERINARY ECONOMICS, 2001, 42 (11): : 16 - 16
  • [10] Maximizing the Clinical Benefit of Novel Therapies in Multiple Myeloma The Laubach article reviewed
    Laubach, Jacob
    Mitsiades, Constantine
    Anderson, Kenneth
    Richardson, Paul
    ONCOLOGY-NEW YORK, 2009, 23 (05): : 415 - 419
12345